Quote from: Leeloo_Dallas on February 02, 2016, 10:06:52 AM
She would not increase my dosage or return to intramuscular because she feels its not safe to go that high. (On a fairly standard dose now).
What are the risks?
1)
Cardiovascular and clotting risks. Studies in men with prostate cancer (ages 49-91) have shown that levels up to 700 pg/ml were safe.
There were no cardiovascular complications or incidences of thrombosis. In fact, researchers stated high levels could be PROTECTIVE. They were treated with high dose injectable or transdermal (patches) estradiol. I can provide you those studies.
. Pregnant women have levels that go as high as 75,000 pg/ml and yet the risk of having a DVT or pulmonary embolism is less than 0.02 % with pulmonary embolism being extremely rare during pregnancy. I can provide you the evidence as well.
. Ciswomen are also reported to be much less affected than men by cardiovascular complications despite pregnancy levels of estradiol and levels of up to 650 pg/ml every menstrual cycle. Their risks increase post-menopause when estrogen levels DROP. Studies have strongly suggested a role for estrogen. I can provide these studies as well.
. Am J Obstet Gynecol. 1993 Dec;169(6):1549-53.
"As serum estradiol levels increased throughout each phase (maximum mean estradiol 739.8 pg/ml)"
"Down-regulation of the fibrinolytic system was observed as estradiol levels increased. However, thrombin formation did not change, thus suggesting that
elevated circulating estradiol alone does not predispose to a thromboembolic event."
. Arch Sex Behav. 1998 Oct;27(5):475-92. In this study, transsexual women were given high dose intramuscular E. Despite 17 people being on this regimen, there was not one incidence of thrombosis.
"None of our patients developed deep vein thrombosis or embolism during cross-gender hormone therapy performed in our clinic."
2)
Breast cancer risk. In transsexual women, breast cancer incidence is very low, equal to that of men not on HRT. Only 10 cases reported since 1968 despite decades of very aggressive, high doses of oral estrogens and non-oral estrogens (intramuscular). Only one case reported in Holland among Gooren's patients in decades of treatment. Studies to support this.
. In men with prostate cancer treated with high dose estrogen over the years, since the 1960's, breast cancer is extremely rare. Supporting evidence.
. High dose estrogen has actually been used to treat ciswomen afflicted with breast cancer.
. Randomized controlled trials (the strongest form of study) showed estrogen to be either protective of breast cancer incidence or have no effect, even in women who had had breast cancer. I can provide studies.
. The more childbirths a woman (hence, the more pregnancies), the lower the risk of breast cancer. On the other hand, celibate nuns are historically known to have a higher incidence of breast cancer risk.
. Breast cancer risk is highest in women over the age of 40 and especially 50,
when estrogen levels drop.
3)
Uterine cancer risk. YOU HAVE NO UTERUS
4)
Prolactinoma. Ciswomen have very high levels of prolactin, up to 210 ng/ml, during pregnancy and continue to have high levels during breastfeeding which can sometimes last a few years. As far as I know, prolactinoma is not more prevalent in women because of this and this has never been called into question by doctors asking mothers to stop breastfeeding their children or not become pregnant again due to risk of prolactinoma.
. In my extensive search through incidences of prolactinoma in transsexual women, the only incidences reported were found to be in those women who took non bio-identical forms of estrogen orally (ethinyl estradiol, DES or conjugated equine estrogens) with or without cyproterone acetate, known to
abnormally elevate prolactin levels. Incidences in women taking bio-identical estradiol without the above mentioned agents taken simultaneously have NEVER been reported to date.
On the flipside, ask her to provide
studies (not statements made by an association) to support her assertions.
By the way, I'm on a high dose of intramuscular E. Supervised by three doctors who approve, one of whom is an author of a book on female hormones, another a trans-specialist endocrinologist from the University of Cambridge. My blood tests results show no change in clotting factor, or liver enzymes, or lipids, insulin, glucose, c-reactive protein. Nothing is out of range given my high levels of E2, which are in the range of 1,000-4,000 pg/ml.